Inhibrx Share Price

Inhibrx Share Price

NASDAQ: INBX | Small Cap | Healthcare
$69.13
-$6.15 (-8.17%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Inhibrx Stock Performance

Open
$72.92
Prev. Close
$75.28
Circuit Range
N/A
Day Range
$69.53 - $72.92
Year Range
$57.63 - $153.68
Volume
10,020
Average Traded
$70.82

Inhibrx Share Price Today

As of 21 November 2026, Inhibrx Biosciences, Inc.'s share price is $69.13. The stock opened at $72.92, compared to its previous close of $75.28. During today's trading session, Inhibrx Biosciences, Inc.'s share price traded between $69.53 and $72.92, with an average price of $71.22. Over the past 52 weeks, the stock has recorded a high of $153.68 and a low of $57.63. In terms of performance, Inhibrx Biosciences, Inc.'s share price has declined by 33.41% over the last six months and is down 18.11% on a year-on-year basis.

Inhibrx Share Price Chart

Line chart of the Inhibrx price trend over the selected period. The price fell overall, ranging from 68.96 to 74.23, ending at 69.13.
$69.53$72.92
L
Show Current Price
H

Inhibrx Stock Fundamentals & Key Indicators

Market Cap
$1.07B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-9.59
Revenue (TTM)
$1.30B
Return On Equity (TTM)
164.96%
Profit Margin
-10773.85%
Debt to Equity
-3.22
Quarterly Earnings Growth YoY
-17.97%

Inhibrx Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$2.00
Net Profit-$32.83-$33.44-$36.65-$38.73
Net Profit MarginN/AN/AN/A-1936.50%
Income ChangeN/A-1.86%-9.60%-5.68%

Inhibrx Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.20$1.30
Net Profit$1687.57-$140.06
Net Profit Margin843785.00%-10773.85%
Income ChangeN/A-108.30%

Inhibrx Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets13.6520.37
Current Assets132.83160.4
Total Assets146.48180.77
Non Current Liabilities104.696.45
Current Liabilities33.840.73
Total Liabilities138.4947.18
Shareholders' Equity7.99133.58

Inhibrx Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-129.79-194.41
Investing-0.03-2.6
Financing101.4571.68

About Inhibrx

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Inhibrx Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$70.90
$69.53
-3.08%
Oct 2026
$99.51
$71.74
-28.56%
Sep 2026
$121.89
$100.42
-19.32%
Aug 2026
$81.20
$124.47
+51.57%
Jul 2026
$94.00
$82.12
-13.19%
Jun 2026
$102.67
$94.60
-8.87%
May 2026
$129.22
$103.81
-19.00%
Apr 2026
$68.46
$128.16
+90.80%
Mar 2026
$72.00
$67.17
-9.46%
Feb 2026
$76.28
$74.19
-3.04%
Jan 2026
$81.85
$76.52
-3.16%
Dec 2025
$82.28
$79.02
-6.40%

Inhibrx Share Price FAQs